Literature DB >> 16084119

Murine models of COPD.

G G Brusselle1, K R Bracke, T Maes, A I D'hulst, K B Moerloose, G F Joos, R A Pauwels.   

Abstract

Chronic obstructive pulmonary disease (COPD) is characterized by airflow limitation, that is not fully reversible, and that is associated with an abnormal inflammatory response of the airways and lungs to noxious particles and gases. The airflow limitation is caused by increased resistance of the small conducting airways and by decreased elastic recoil forces of the lung due to emphysematous destruction of the lung parenchyma. In vivo animal models can help to unravel the molecular and cellular mechanisms underlying the pathogenesis of COPD. Mice represent the most favored animal species with regard to the study of (both innate and adaptive) immune mechanisms, since they offer the opportunity to manipulate gene expression. Several experimental approaches are applied in order to mimic the different traits of COPD in these murine models. Firstly, the tracheal instillation of tissue-degrading enzymes induces emphysema-like lesions in the lung parenchyma, adding further proof to the protease-antiprotease imbalance hypothesis. Secondly, the inhalation of noxious stimuli, including tobacco smoke, sulfur dioxide, nitrogen dioxide, or oxidants such as ozone, may also lead to COPD-like lesions in mice, depending on concentration, duration of exposure and strainspecific genetic susceptibility. Thirdly, in transgenic mice, a specific gene is either overexpressed (non-specific or organ-specific) or selectively depleted (constitutively or conditionally). The study of these transgenic mice, either per se or in combination with the above mentioned experimental approaches (e.g. the inhalation of tobacco smoke), can offer valuable information on both the physiological function of the gene of interest as well as the pathophysiological mechanisms of diseases with complex traits such as COPD.

Entities:  

Mesh:

Year:  2005        PMID: 16084119     DOI: 10.1016/j.pupt.2005.06.001

Source DB:  PubMed          Journal:  Pulm Pharmacol Ther        ISSN: 1094-5539            Impact factor:   3.410


  19 in total

Review 1.  Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases.

Authors:  Brice Korkmaz; Marshall S Horwitz; Dieter E Jenne; Francis Gauthier
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

2.  Impact of the loss of Hoxa5 function on lung alveogenesis.

Authors:  Isabel Mandeville; Josée Aubin; Michelle LeBlanc; Mélanie Lalancette-Hébert; Marie-France Janelle; Guy M Tremblay; Lucie Jeannotte
Journal:  Am J Pathol       Date:  2006-10       Impact factor: 4.307

3.  Monitoring in vivo changes in lung microstructure with ³He MRI in Sendai virus-infected mice.

Authors:  Wei Wang; Nguyet M Nguyen; Eugene Agapov; Michael J Holtzman; Jason C Woods
Journal:  J Appl Physiol (1985)       Date:  2012-03-01

4.  Fluoxetine, an Antidepressant Drug, Inhibited Cigarette Smoke-Induced Pulmonary Inflammation and Apoptosis in Rats.

Authors:  Zhiyong Cai; Jindi Liu; Hongliang Bian; Jinlan Cai; Qing Jin; Jijing Han
Journal:  Inflammation       Date:  2017-08       Impact factor: 4.092

Review 5.  Animal models of chronic obstructive pulmonary disease.

Authors:  Joanne L Wright; Manuel Cosio; Andrew Churg
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-05-02       Impact factor: 5.464

6.  Double deficiency of tetraspanins CD9 and CD81 alters cell motility and protease production of macrophages and causes chronic obstructive pulmonary disease-like phenotype in mice.

Authors:  Yoshito Takeda; Ping He; Isao Tachibana; Bo Zhou; Kenji Miyado; Hideshi Kaneko; Mayumi Suzuki; Seigo Minami; Takeo Iwasaki; Sho Goya; Takashi Kijima; Toru Kumagai; Mitsuhiro Yoshida; Tadashi Osaki; Toshihisa Komori; Eisuke Mekada; Ichiro Kawase
Journal:  J Biol Chem       Date:  2008-07-28       Impact factor: 5.157

Review 7.  Barriers to inhaled gene therapy of obstructive lung diseases: A review.

Authors:  Namho Kim; Gregg A Duncan; Justin Hanes; Jung Soo Suk
Journal:  J Control Release       Date:  2016-05-16       Impact factor: 9.776

8.  HE3286, an oral synthetic steroid, treats lung inflammation in mice without immune suppression.

Authors:  Douglas Conrad; Angela Wang; Raymond Pieters; Ferdinando Nicoletti; Katia Mangano; Anna M van Heeckeren; Steven K White; James M Frincke; Christopher L Reading; Dwight Stickney; Dominick L Auci
Journal:  J Inflamm (Lond)       Date:  2010-10-30       Impact factor: 4.981

9.  Lung volumes and respiratory mechanics in elastase-induced emphysema in mice.

Authors:  Z Hantos; A Adamicza; T Z Jánosi; M V Szabari; J Tolnai; B Suki
Journal:  J Appl Physiol (1985)       Date:  2008-10-09

Review 10.  Mouse models to unravel the role of inhaled pollutants on allergic sensitization and airway inflammation.

Authors:  Tania Maes; Sharen Provoost; Ellen A Lanckacker; Didier D Cataldo; Jeroen A J Vanoirbeek; Benoit Nemery; Kurt G Tournoy; Guy F Joos
Journal:  Respir Res       Date:  2010-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.